T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis

Science. 1994 Feb 25;263(5150):1139-43. doi: 10.1126/science.7509084.

Abstract

Encounters with antigen can stimulate T cells to become activated and proliferate, become nonresponsive to antigen, or to die. T cell death was shown to be a physiological response to interleukin-2-stimulated cell cycling and T cell receptor reengagement at high antigen doses. This feedback regulatory mechanism attenuates the immune response by deleting a portion of newly dividing, antigen-reactive T cells. This mechanism deleted autoreactive T cells and abrogated the clinical and pathological signs of autoimmune encephalomyelitis in mice after repetitive administration of myelin basic protein.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens / immunology*
  • Apoptosis
  • CD4-Positive T-Lymphocytes / immunology*
  • Cell Division
  • Cells, Cultured
  • Cytochrome c Group / immunology
  • Dose-Response Relationship, Immunologic
  • Encephalomyelitis, Autoimmune, Experimental / immunology*
  • Encephalomyelitis, Autoimmune, Experimental / pathology
  • Encephalomyelitis, Autoimmune, Experimental / therapy
  • Immune Tolerance*
  • Immunotherapy
  • Interleukin-2 / immunology
  • Interleukin-2 / pharmacology
  • Lymphocyte Activation
  • Mice
  • Mice, Transgenic
  • Myelin Basic Protein / immunology
  • Myelin Sheath / immunology
  • Myelin Sheath / pathology
  • Spinal Cord / pathology
  • T-Lymphocytes / immunology*

Substances

  • Antigens
  • Cytochrome c Group
  • Interleukin-2
  • Myelin Basic Protein